Blood News and Research

RSS

Blood cells returned to stem cell state by Johns Hopkins researchers

Johns Hopkins scientists have developed a reliable method to turn the clock back on blood cells, restoring them to a primitive stem cell state from which they can then develop into any other type of cell in the body.

22 Aug 2012

Miniaturized wireless sensors can save lives of wounded soldiers

Early detection of blood loss to save the lives of soldiers wounded on the battlefield is the goal of a three-year research and development project to be launched this fall at Worcester Polytechnic Institute (WPI). Funded by a $1.9 million grant from the U.S. Army, the research will be conducted in collaboration with the University of Massachusetts Medical School (UMMS).

22 Aug 2012

FDA warns consumers about potential health risks of two natural dietary supplements

The U.S. Food and Drug Administration today issued a new warning to consumers about the potential health risks of two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions.

22 Aug 2012

Study identifies certain small molecule chemicals that can disrupt quorum sensing in A. baumanni

Acinetobacter baumanni, a pathogenic bacterium that is a poster child of deadly hospital acquired infections, is one tough customer.

22 Aug 2012

Study uses cardiac CT to detect presence of blocked arteries in older marathoners

A study of marathon participants older than 50 years of age has found similar temporary effects as those found in runners between 18 and 40 years of age. Any cardiac abnormalities during a marathon disappear within a week after completing a race.

22 Aug 2012

IntelliCell seeks patent for new mechanical method to separate SVF from blood vessels in fat

IntelliCell BioSciences, Inc. announced today that it has filed a patent application for a new mechanical method to separate stromal vascular fraction (SVF) from the blood vessels in adipose tissue (fat) to be used clinically in regenerative medicine.

22 Aug 2012

Final data from Symphogen's rozrolimupab Phase 2 trial on primary immune thrombocytopenia

The hematology journal BLOOD published today a full-length article describing final Phase 2 data for Symphogen's rozrolimupab, a novel human recombinant mixture of 25 antibodies which all are manufactured simultaneously from a single batch.

22 Aug 2012

Efforts to tackle excess weight among disadvantaged groups are urgently needed

The authors say further efforts to tackle these risk factors, particularly excess weight, among disadvantaged groups are urgently needed.

22 Aug 2012

Brand-name drug makers bet coupons will help their products edge out generic competition

If brand-name prescription medicines cost you as little as generic pills, which would you choose? A few drugmakers are betting Americans will stick with the name they know. They've begun offering U.S. patients coupons to reduce copayments on brand-name medicines and compete with new generic versions of the drugs.

22 Aug 2012

Arteriocyte receives NIH grant for use of NANEX platform in bone marrow transplant

Arteriocyte, a leading clinical stage biotechnology company developing cellular based therapies to treat human diseases, announced today the successful award of another grant by the National Institute of Health for the use of the NANEX platform in Hematopoietic Reconstitution Using Ex Vivo Expanded Umbilical Cord Blood CD34+ Stem Cells.

22 Aug 2012

Viewpoints: The importance of hepatitis C testing; Medicaid needs to provide coverage for circumcision

I consider myself to be a fortunate person. I have a good education, a great job and excellent health insurance. I am a baby boomer who has aged reasonably well and can look forward to a fairly comfortable retirement. I am also fortunate because I was diagnosed with hepatitis C by a proactive and knowledgeable doctor in the late 1990s and had the opportunity to be treated and cured. The odds are that if I had not been diagnosed and treated, I would be on a liver transplant list right now, have liver cancer or even be dead from this disease.

22 Aug 2012

Coronary artery calcium tool proves effective in detecting risk of cardiovascular disease

Heart calcium scans are far superior to other assessment tools in predicting the development of cardiovascular disease in individuals currently classified at intermediate risk by their doctors, according to researchers at Wake Forest Baptist Medical Center.

22 Aug 2012

Endovascular brachytherapy may safely and effectively treat femoropopliteal in-stent stenosis

Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.

22 Aug 2012

OBI’s Oxycyte improves imaging of penumbra following acute ischemic stroke

Oxygen Biotherapeutics, Inc., announced today that recent research conducted by its partner, Aurum Biosciences, Glasgow, Scotland, has shown that Oxycyte, OBI's proprietary perfluorocarbon-based intravenous emulsion, improves imaging of the penumbra following acute ischemic stroke in a rat model.

22 Aug 2012

CIRT to determine whether methotrexate can reduce heart attacks, strokes and CVD deaths

An international multi-site trial has launched to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes, and deaths due to cardiovascular disease in people at high risk for them. This study is being supported by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health.

22 Aug 2012

Working memory capacity in patients with Parkinson's can be improved with sleep

People with Parkinson's disease performed markedly better on a test of working memory after a night's sleep, and sleep disorders can interfere with that benefit, researchers have shown.

22 Aug 2012

Sotera Wireless receives FDA 510(k) clearance for ViSi Mobile System

Sotera Wireless, Inc. announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its full ViSi Mobile System and is commencing sales to hospitals nationwide.

22 Aug 2012

VolitionRX to initiate NuQ blood-based tests in colorectal cancer clinical trial

VolitionRX Limited, a life sciences company focused on developing blood-based diagnostic tests, announces that its subsidiary Belgian Volition has signed an agreement with the Biobank of CHU UCL Mont-Godinne, an academic hospital in Yvoir, Belgium.

22 Aug 2012

Healthcare announces important changes to the U.S. product label for Optison

GE Healthcare today announced important changes to the U.S. product label for Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a contrast agent that may improve the visualization of the left ventricular border - an area of the heart that is critical to see in order to diagnose certain heart diseases such as hypertrophic cardiomyopathy.

22 Aug 2012

GM-CSF depletion suppresses pain in people with arthritis-related conditions

The research relates to a family of molecules firstly discovered in Melbourne that applied to blood cell development. One of these, granulocyte macrophage colony-stimulating factor or GM-CSF, acts as a messenger between cells acting at a site of inflammation.

22 Aug 2012

Blood News and Research

Blood cells returned to stem cell state by Johns Hopkins researchers

Miniaturized wireless sensors can save lives of wounded soldiers

FDA warns consumers about potential health risks of two natural dietary supplements

Study identifies certain small molecule chemicals that can disrupt quorum sensing in A. baumanni

Study uses cardiac CT to detect presence of blocked arteries in older marathoners

IntelliCell seeks patent for new mechanical method to separate SVF from blood vessels in fat

Final data from Symphogen's rozrolimupab Phase 2 trial on primary immune thrombocytopenia

Efforts to tackle excess weight among disadvantaged groups are urgently needed

Brand-name drug makers bet coupons will help their products edge out generic competition

Arteriocyte receives NIH grant for use of NANEX platform in bone marrow transplant

Viewpoints: The importance of hepatitis C testing; Medicaid needs to provide coverage for circumcision

Coronary artery calcium tool proves effective in detecting risk of cardiovascular disease

Endovascular brachytherapy may safely and effectively treat femoropopliteal in-stent stenosis

OBI’s Oxycyte improves imaging of penumbra following acute ischemic stroke

CIRT to determine whether methotrexate can reduce heart attacks, strokes and CVD deaths

Working memory capacity in patients with Parkinson's can be improved with sleep

Sotera Wireless receives FDA 510(k) clearance for ViSi Mobile System

VolitionRX to initiate NuQ blood-based tests in colorectal cancer clinical trial

Healthcare announces important changes to the U.S. product label for Optison

GM-CSF depletion suppresses pain in people with arthritis-related conditions

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News